Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-06-14
2011-06-14
Jarrell, Noble (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S429000, C546S275400, C548S377100
Reexamination Certificate
active
07960413
ABSTRACT:
Compounds of the formula (I) and salts and solvates thereof, in which X, R1, R2, R3, R4, R5and R6have the meanings indicated in Claim1, are suitable as ligands of 5 HT receptors.
REFERENCES:
patent: 3926999 (1975-12-01), Poetsch
patent: 4146721 (1979-03-01), Rainer
patent: 4258047 (1981-03-01), Gante et al.
patent: 4325962 (1982-04-01), Rainer
patent: 4631343 (1986-12-01), Beck
patent: 6043261 (2000-03-01), Hansen, Jr. et al.
patent: 6100259 (2000-08-01), Xiang et al.
patent: 6150393 (2000-11-01), Behan et al.
patent: 6407238 (2002-06-01), Baron et al.
patent: 7067507 (2006-06-01), Pulley et al.
patent: 7368578 (2008-05-01), Momose et al.
patent: 2001/0044445 (2001-11-01), Bamaung et al.
patent: 2002/0091116 (2002-07-01), Zhu et al.
patent: 2004/0034083 (2004-02-01), Stephenson et al.
patent: 2005/0239797 (2005-10-01), Gaster et al.
patent: 2006/0264419 (2006-11-01), Schiemann et al.
patent: 2006/0276650 (2006-12-01), Schadt et al.
patent: 2007/0010531 (2007-01-01), Schadt et al.
patent: 2007/0093492 (2007-04-01), Jiaang et al.
patent: 2007/0105871 (2007-05-01), Schiemann et al.
patent: 2141125 (1972-02-01), None
patent: 2201889 (1973-07-01), None
patent: 2258033 (1974-05-01), None
patent: 2906252 (1980-08-01), None
patent: WO 96/33175 (1996-10-01), None
patent: WO9831227 (1998-07-01), None
patent: WO 9831227 (1998-07-01), None
patent: WO 01/29008 (2001-04-01), None
patent: WO 0132626 (2001-05-01), None
patent: WO 0132627 (2001-10-01), None
patent: WO03031345 (2003-04-01), None
patent: WO 03031435 (2003-04-01), None
patent: WO 03088958 (2003-10-01), None
patent: WO 03/099793 (2003-12-01), None
patent: WO 2004/024705 (2004-03-01), None
patent: WO 2004/024705 (2004-05-01), None
patent: WO 2004/037248 (2004-05-01), None
Vippagunta et al. Advanced Drug Delievery Reviews, 2001, 48, 3-26.
Ross et al. Expert Opinion on Therapeutic Patents, 2003, 13(10), 1491-99.
“Combat”, http://www.aolsvc.merriam-webster.aol.com/dictionary/combating, accessed Nov. 20, 2009.
Portnoy. Journal of Heterocyclic Chemistry, 1969, 6(2), 223-8, STN record.
Database Beilstein ′Online! Beilstein Institute for Organic Chemistry, Frankfurt-Main, DE; Jun. 27, 1988, XP002283830.
Database Beilstein ′Online! Beilstein Institute for Organic Chemistry, Frankfurt-Main, Jun. 27, 1988, XP002283830.
Vippagunta et al. Advanced Drug Delivery Reviews, 2001, 48, 3-26.
“Premenstrual syndrome—Womens health and Medical Information in Medicinenet.com”, http://www.medicinenet.com/premenstrual—syndrome/page5.htm, accessed Sep. 19, 2007.
“Amyotrophic Lateral sclerosis information page: National Institute of Neurological Disorders and Stroke (NINDS)”, http://www.ninds.gov/disorders/amyotrophiclateralsclerosis/amyotrophiclateralsclerosis.htm, accessed Sep. 19, 2007.
“Obsessive-compulsive behaviors and disorders: symptoms, treatment, and support”, http://www.helpguide.org/mental/obsessive—compulsive—disorder—ocd.htm, accessed Sep. 19, 2007.
Journal of Clinical Psychiatry, 1999, 60, 1-8.
Crow, S. Expert Opinion on Investigational Drugs, 1997, 6(4), 427-36.
Ross et al., Expert Opinion on Therapeutic Patents, 2003, 13(10), 1491-99.
Takehito Ochi et al.: “FR143166 Attenuates Spinal Pain Transmission Through Activation of the Serotonig System” European Journal of Pharmacology, Bd. 452, 2002, pp. 319-324, XP002284473, The Entire Document.
Yoshiko Suzuki et al: “In Vitro and In Vivo Pharmacological Profile of 4-(4-Fluorobenzylidene)-1-{2-′5-(4-Fluorop Henyl)-1H-Pyrazol-4-Yl!Ethyl} Piperidine (NRA0161)” Life Sciences, Bd. 71, 2002, pp. 2603-2615, XP002284474, The Entire Document.
Katritzky et al: “1,3-Dipolar Cycloadditions of Electron-Rich Benzotriazol-1-Ylpropenes” J. Heterocyclic Chem., Bd. 33, 1996, pp. 1637-1646, XP002284475, Figure 28, pp. 1640.
Perez et al: “An Easy Method for the N-Alkylation of Amides, Carbamates, Ureas and Azoles . . . ” Heterocycles, Bd. 60, Nr. 1, Nov. 25, 2002, pp. 167-175, XP002284476, Figures 10,11 and 12, pp. 168 and 173.
Database Chemabs ′Online! Chemical Abstracts Service, Columbus, Ohio, US; 1960, Grandberg, I.I. et al: “Pyrazoles. XII. Hydroxy-and Chloromethylation of 1-Substituted Pyrazoles” XP002284480, Found in STN, Database Accession No. 1961:99421, Summary & Zhurnal Obshchei Khimii, 30, 3324-8; CODEN: ZOKHA4; ISSN: 0044-460X, 1960.
Database Beilstein; Beilstein Institute for Organic Chemistry, Frankfurt-Main, DE; Nov. 29, 1988; XP002284481, Database Accession No. BRN 1127514 CAS-RN; 35000-58-9/ Summary & Dorn et al: J. Prakt. Chem., Bd. 313, 1971, pp. 236-246.
Bebernitz et al.: “The Effect of 1,3-Diaryl-′1H!-Pyrazol-4-Acetamides on Glucose Utilization in OB/OB Mice” J. Med. Chem., Bd. 44, Nr. 16, 2001, pp. 2601-2611, XP002284478; Schema 1, Methode A, Strukturen 2-5, Reaktionen A and B.
Echevarria et al: Research in the Azole Series. 102 ′1!. Synthesis and 13C NMR Study of Pyrazole-4-Carboxaldehydes: J. Heterocyclic Chem., Bd. 30, 1993, pp. 957-960, XP002284479, Formula 19, p. 957.
Database Beilstein, Beilstein Institute for Organic Chemistry, Frankfurt-Main, DE; Jan. 24, 2002, XP002284482, Database Accession No. BRN 8913586 & Bratenko et al: Russ. J. Org. Chem. EN, Bd. 37, Nr. 4, 2001, pp. 552-555.
Caramella, et al., Heterocycles, vol. 40, No. 2, 1995, pp. 515-520.
Non Final Rejection dated May 7, 2007—U.S. Appl. No. 10/552,064, filed Oct. 5, 2005 (Publication No. US-2007-0010531-A1).
Non Final Rejection dated Sep. 29, 2007—U.S. Appl. No. 10/552,064, filed Oct. 5, 2005 (Publication No. US-2007-0010531-A1).
Final Rejection dated Jul. 9, 2008—U.S. Appl. No. 10/552,064, filed Oct. 5, 2005 (Publication No. US-2007-0010531-A1).
Non Final Rejection dated Nov. 20, 2007—U.S. Appl. No. 10/551,998, filed Oct. 5, 2006 (Publication No. US-2007-0105871-A1).
Final Rejection dated Aug. 7, 2008—U.S. Appl. No. 10/551,998, filed Oct. 5, 2006 (Publication No. US-2007-0105871-A1).
Non Final Rejection dated Aug. 25, 2008—U.S. Appl. No. 10/552,065, filed Oct. 5, 2005 (Publication No. US-2006-0264419-A1).
O'Brian et al: “Some Reactions of 3-Hydroxy-1-Phenylpyrazole” J. Org. Chem., Bd.31, 1966, pp. 1538-1542, XP002284477, The Entire Document.
Bartoszyk Gerd
Schadt Oliver
Schiemann Kai
Seyfried Christoph
Van Amsterdam Christoph
Jarrell Noble
Merck Patent GmbH
Millen White Zelano & Branigan P.C.
LandOfFree
Pyrazole compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrazole compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazole compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2663642